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nhe term hypoplastic left heart syndrome (HLHS) de-
scribes a group of cardiac malformations that result in a
iminutive or absent left ventricle and a hypoplastic ascend-
ng aorta; these structures are inadequate to supply the sys-
emic circulation. Mitral or aortic valve hypoplasia or atresia
ay accompany the syndrome. The circulation is dependent
n the patency of the ductus arteriosus as well as onmixing of
ystemic and pulmonary venous blood.1 This syndrome is
he most common severe congenital heart defect; it repre-
ents 7 to 9% of all congenital cardiac anomalies.2
The earliest attempt to provide palliation for HLHS in-
olved a graft that connected the right ventricle to the de-
cending aorta, and pulmonary blood flow was controlled
ith bilateral banding. These attempts were troubled by pul-
onary arterial distortion, but they laid the groundwork for
he development, largely by Dr. William I. Norwood, of the
rst successful newborn palliative reconstruction. The cur-
ent staged approach to palliation described by Norwood3
as changed little in the past two decades, but there are some
ecently proposed, potentially important technical modifica-
ions currently under investigation. An alternative therapy is
ardiac transplantation; this strategy was pioneered by Bailey
nd colleagues, but it is limited by donor organ availability.4
The principles of the staged reconstruction are similar to
hose for other single ventricle anomalies. The goals of the
rst stage procedure are (i) creation of an unobstructed con-
ection between the aorta and the systemic ventricle, (ii)
egulation of pulmonary blood flow, and (iii) creation of an
nobstructed interatrial communication.3,5 Retrograde per-
usion of the ascending aorta must be provided to avoid cor-
nary underperfusion. Significant AV valve regurgitation
ay be addressed; alternatively very severe regurgitationmay
ontraindicate a staged approach in favor of primary trans-
lantation.
The second stage is performed at 3 to 6 months of age and
nvolves division of the systemic to pulmonary shunt and
reation of a bidirectional Glenn or hemi-Fontan connection.
his serves to unload significantly the single ventricle and
lso to create a more reliable source of pulmonary blood flow
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oi:10.1053/j.optechstcvs.2005.12.002han the previously shunt-dependent circulation. The final
tage is a modified Fontan–Kreutzer procedure in which total
avopulmonary connection is achieved with an intraatrial
ateral tunnel or extracardiac connection.3
reoperative Preparation
nd Anesthetic Considerations
reviously undiagnosed HLHSmanifests as severely compro-
ised systemic perfusion when the ductus arteriosus begins
o close. Significant organ dysfunction and frank shock can
nsue. Echocardiography is the mainstay of diagnosis and
herefore must be undertaken rapidly when HLHS is sug-
ested. The clinical situation is greatly worsened by the pres-
nce of a restrictive atrial septal defect (2 to 5% of cases),
hich causes an obstruction of pulmonary venous outflow
ith resultant congestion, hypoxemia, and pulmonary dis-
ase. Restrictive atrial septal defects require dilation in the
atheterization laboratory or emergent septectomy or com-
lete surgical correction.
Medical therapy for HLHS is undertaken as soon as the
iagnosis is made and involves maintaining ductal patency
ith a continuous infusion of prostaglandin E1 (0.025 to
.05 g/kg/min). Spontaneous ventilation is preferred in
hese patients, although many will develop apnea related to
he prostaglandins and require mechanical ventilation. Ex-
essive oxygen administration is avoided in an attempt to
alance pulmonary and systemic flow. Occasionally inspired
arbon dioxide is helpful in controlling pulmonary overcir-
ulation, and it may improve cerebral circulation. It is gen-
rally possible to stabilize these patients medically and to
llow for recovery of end-organ dysfunction before surgical
ntervention.
perative Technique
t the Children’s
ospital of Philadelphia
he operative technique for the Stage I reconstruction for
LHS utilized at the Children’s Hospital of Philadelphia re-
ies heavily on the technique described by Dr. Norwoodmore
han 20 years ago.3,5 Deep hypothermic circulatory arrest is
mployed for the reconstruction. We do not employ retro-
rade or selective cerebral perfusion, although these tech-
iques are favored by some centers. We do not believe that
he data available to date show any clear benefit arising from
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300 D.B. Meyer and T.L. Sprayelective or retrograde perfusion as compared with circula-
ory arrest6-9; moreover these perfusion techniques can be
umbersome and interfere with precise reconstruction.
Pulmonary blood flow is generally provided via a modified
lalock–Taussig shunt from the right innominate artery to
he pulmonary artery. This shunt is relatively small, sized 3.5
o 4.0 mm, and is chosen so as to be the limiting factor for
ulmonary blood flow. Providing limitation of pulmonary
lood flow at the level of the shunt facilitates postoperative
anagement by rendering traditional manipulations of the
entilator to modify pulmonary vascular resistance unneces- t
 right ventricle; SVC  superior vena cava artery.ary.10 Recently a right ventricle to pulmonary artery con-
uit11 has been employed in a minority of cases. The precise
etermination of the relative benefit of this conduit awaits the
esults of ongoing investigation.
The creation of the neoaorta begins with a side-to-side
onnection of the aorta to the pulmonary artery. The arch
s augmented with a patch of pulmonary homograft, and
esection of the coarctation segment is rarely performed.
e believe that the tailoring of the patch is key to mini-
izing the risk of arch obstruction, and the details of ourechnique are described.Figure 1 Initial exposure is via a median sternotomy. The thymus is removed and the pericardium opened in the
midline. Lymphoid tissue between the superior vena cava and aorta overlying the trachea is removed to allow the shunt
to lie properly. The diminutive aorta is fully mobilized off the pulmonary artery. The arch is mobilized into the
descending aorta, beyond the ductal insertion. Tourniquets are passed around the arch vessels (except the innominate
artery), and the right and left pulmonary arteries. Ao aorta; MPAmain pulmonary artery; RA right atrium; RV
m; RV  right ventricle; SVC  superior vena cava artery.
Stage I—The Philadelphia approach 301Figure 2 After systemic heparinization the pulmonary
pulmonary valve sinuses, and a single venous cannula is
instituted, the snares on the pulmonary arteries are tigh
aorta; MPA  main pulmonary artery; RA  right atriuartery is cannulated proximal to its bifurcation, above the
placed in the right atrium. When cardiopulmonary bypass is
tened to direct perfusion through the ductus arteriosis. Ao 
urniquet is then placed around the innominate artery.
302 D.B. Meyer and T.L. SprayFigure 3 Bypass is instituted and the patient is cooled to
(usually 3.5 or 4.0 mm) is created to the proximal innom
shunt to its appropriate length before circulatory arrest, w
of the shunt, it is gently occluded with a hemoclip. A to18°C. During cooling the proximal anastamosis of the shunt
inate artery with 7.0 monofilament suture. It is best to cut the
hile the structures are still filled with blood. After completion
Stage I—The Philadelphia approach 303Figure 4 When the patient is adequately cooled, circulato
on the pulmonary arteries are tightened. With a clamp p
administered via a sidearm connector on the arterial
pulmonary arteries are removed.ry arrest is initiated. The snares on the aortic arch vessels and
laced on the aorta distal to the ductal insertion, cardioplegia is
line. After administration of cardioplegia, the snares on the
leaving the tie on the pulmonary artery side.
304 D.B. Meyer and T.L. SprayFigure 5 The ductus is tied and divided,
venous purse-string or through a separate atriotomy.
Stage I—The Philadelphia approach 305Figure 6 The atrial septum is excised through the
306 D.B. Meyer and T.L. SprayFigure 7 The pulmonary artery is divided transversely at
at the origin of the right pulmonary artery ensures that th
not interfere with the coronary arteries. The distal pulmo
patch. MPA  main pulmonary artery.the origin of the right pulmonary artery. Making this division
e connection of the PA to the aorta is distal enough that it does
nary artery is closed primarily or with a pulmonary homograft
Stage I—The Philadelphia approach 307Figure 8 The distal anastomosis of the shunt is created to the right pulmonary artery very proximally (almost at the
origin of the right pulmonary artery) with 7.0 monofilament suture. The hatched line demonstrates the incision to be
made starting in the diminutive ascending aorta and carried beyond the ductal insertion. RPA  right pulmonary
artery.Figure 9 After the aorta is opened, the ridge of ductal tissue at the coarctation is excised. In a small proportion of cases
the coarctation segment is resected (inset).
the aortic incision.
308 D.B. Meyer and T.L. SprayFigure 10 The creation of the neoaorta begins with app
several interrupted sutures of 7.0 prolene. Occasionally
(inset), but usually the connection is created without th
coronary blood flow due to distortion of the diminut
pulmonary valve are generally positioned at the level ofroximation of the aorta and proximal pulmonary artery with
a “cutback” is created into the sinus of the pulmonary artery
is slit. The purpose of the “cutback” is to prevent limitation of
ive aorta. If the “cutback” is made, the commissures of the
e patch to be slightly too narrow rather than slightly too wide.
Stage I—The Philadelphia approach 309Figure 11A Next the aorta is augmentedwith a patch of pu
geometry is complex. Generally as the suture line of the
to narrow the patch posteriorly by removing a piece o
twisting of the reconstruction. In general it is better for thlmonary homograft, starting distally. The tailoring of the patch
patch is brought under the arch vessels, it becomes necessary
f homograft (shown with hatchmarks), to avoid kinking and
id kinking of the reconstruction.
310 D.B. Meyer and T.L. SprayFigure 11B The portion of the patch that gets sewn to t
concave, by removing the hatched segment, also to avohe pulmonary artery needs to be further tailored so as to be
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Stage I—The Philadelphia approach 311s rewarming progresses after completion of the reconstruc-
ion, low-dose inotropic support with dopamine 3 g/kg/
in is begun, and generally, a phosphodiesterase inhibitor
milrinone) is administered in the bypass circuit. The patient
s weaned from bypass and modified ultrafiltration is per-
ormed. Milrinone is continued to reduce systemic vascular
esistance and to promote systemic perfusion. In the majority
f cases no additional inotropic support is required, although
hese agents are used if ventricular function is significantly
iminished. The chest is closed in the majority of cases (ap-
roximately 75%) if bleeding. Routine paralysis is not con-
inued beyond the first postoperative night, to avoid delay in
xtubation and in diuresis. Weaning of inspired oxygen to
ontoxic levels is generally accomplished rapidly. Ventilation
s maintained at relatively high tidal volumes to prevent atel-
ctasis and alveolar hypoxemia. Patients are generally al-
owed to awaken on the first postoperative morning and are
xtubated as soon as possible. Milrinone is transitioned to
Figure 12 The comaptopril, and aspirin is administered in an effort to prevent mhunt thrombosis. Recently a low-dose heparin infusion has
een utilized starting the night of surgery and continuing
ntil enteral administration of aspirin is tolerated.
esults
he outcome of patients undergoing Stage 1 palliation for
LHS at the Children’s Hospital of Philadelphia has been
eported previously. In a cohort of 102 patients with HLHS,
perative survival was 78%, and 1-year survival was 66%.
or survivors of the stage 1 operation, 1-year survival was
6%.12 Risk factors for mortality included a low birth weight
2.5 kg), the presence of associated cardiac anomalies, the
eed for mechanical circulatory support, and the presence of
genetic syndrome or extracardiac anomaly. In the absence
f a low birth weight and cardiac or extracardiac anomaly, the
perative survival was 88%. This is consistent with reports
rom other institutions.13 Early mortality is now related pri-
reconstruction.arily to noncardiac abnormalities such as necrotizing en-
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312 D.B. Meyer and T.L. Sprayerocolitis, neurologic dysfunction, or infection. Thus hospi-
al survival for patients with HLHS now approaches that of
any other forms of critical congenital heart disease.
hether this survival will be further increased by any of the
echnical modifications being proposed now, or by fetal di-
gnosis and intervention, remains to be elucidated.
As survival following the Stage 1 operation has improved,
here has been increasing interest in the neurodevelopmental
utcome in patients with HLHS. There is ample evidence that
hese patients are at risk for neurodevelopmental delay; this
an potentially be traced to preoperative decreased cerebral
lood flow and organ dysfunction,14 operative factors such as
irculatory arrest or low flow bypass, or postoperative events
f hemodynamic instability and chronic cyanosis.6 Motor
kills and attention seem to be at greater risk than verbal
kills. The majority of the children remain in the low normal
Q range. The presence of genetic syndrome or perioperative
eurologic dysfunction as evidenced by a seizure disorder
ost strongly portends delayed neurodevelopmental out-
ome. It is hoped that as techniques for perioperative man-
gement and for surgical correction are further refined, im-
rovement in neurological outcome will continue.
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